Collectively, trials found that fluvoxamine’s probability of reducing the risk of hospitalization is between 94.1 and 98.6%, which would be remarkable if reproduced at a large scale.

Topline Fluvoxamine, a cheap and widely available pill used around the world to treat mental illness, is very likely to reduce the risk of being hospitalized with Covid-19, according to new peer ...

In this phase 3, double-blind, randomized, placebo-controlled trial, we used a 2-by-3 factorial design to test the effectiveness of three repurposed drugs — metformin, ivermectin, and ...

The antidepressant fluvoxamine reduced the need for hospitalization among high-risk patients with COVID-19, according to results of the randomized, placebo-controlled TOGETHER trial ...

A safe, well-established antidepressant pill has proven effective at heading off severe COVID-19 cases, recent studies indicate. Fluvoxamine dramatically reduced the risk of hospitalization for ...

With fluvoxamine, doctors find an old drug that may actually work against COVID-19 Medical students and staff members of a Houston hospital prepare for a shift dealing with COVID-19 patients ...

A cheap, generically available anti-depressant may reduce the risk of severe Covid-19 disease by close to a third in people at high risk, researchers reported Wednesday.

The antidepressant drug fluvoxamine, sold under the name Luvox, prevented serious complications in COVID-19 patients who chose to take it. In comparison, some people who did not take the ...

A widely available antidepressant holds promise as a treatment for Covid-19, according to a new study. Covid-19 patients who received fluvoxamine were significantly less likely to require ...

Science Space Animals Health Environment Health What is fluvoxamine, the antidepressant drug that shows promise in treating covid-19? Updated October 28, 2021 More than 3 years ago Summary ...